16045483|t|Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
16045483|a|Point mutations such as G93A and A4V in the human Cu/Zn-superoxide dismutase gene (hSOD1) cause familial amyotrophic lateral sclerosis (fALS). In spite of several theories to explain the pathogenic mechanisms, the mechanism remains largely unclear. Increased activity of glycogen synthase kinase-3 (GSK-3) has recently been emphasized as an important pathogenic mechanism of neurodegenerative diseases, including Alzheimer's disease and ALS. To investigate the effects of G93A or A4V mutations on the phosphatidylinositol-3-kinase (PI3-K)/Akt and GSK-3 pathway as well as the caspase-3 pathway, VSC4.1 motoneuron cells were transfected with G93A- or A4V-mutant types of hSOD1 (G93A and A4V cells, respectively) and, 24 h after neuronal differentiation, their viability and intracellular signals, including PI3-K/Akt, GSK-3, heat shock transcription factor-1 (HSTF-1), cytochrome c, caspase-3 and poly(ADP-ribose) polymerase (PARP), were compared with those of wild type (wild cells). Furthermore, to elucidate the role of the GSK-3beta-mediated cell death mechanism, alterations of viability and intracellular signals in those mutant motoneurons were investigated after treating the cells with GSK-3beta inhibitor. Compared with wild cells, viability was greatly reduced in the G93A and A4V cells. However, the treatment of G93A and A4V cells with GSK-3beta inhibitor increased their viability by activating HSTF-1 and by reducing cytochrome c release, caspase-3 activation and PARP cleavage. However, the treatment did not affect the expression of PI3-K/Akt and GSK-3beta. These results suggest that the G93A or A4V mutations inhibit PI3-K/Akt and activate GSK-3beta and caspase-3, thus becoming vulnerable to oxidative stress, and that the GSK-3beta-mediated cell death mechanism is important in G93A and A4V cell death.
16045483	8	17	GSK-3beta	Gene	2932
16045483	67	71	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	75	78	A4V	ProteinMutation	tmVar:p|SUB|A|4|V;HGVS:p.A4V;VariantGroup:1;CorrespondingGene:6647;CorrespondingSpecies:9606
16045483	86	91	hSOD1	Gene	6647
16045483	122	126	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	142	147	human	Species	9606
16045483	148	174	Cu/Zn-superoxide dismutase	Gene	6647
16045483	181	186	hSOD1	Gene	6647
16045483	194	232	familial amyotrophic lateral sclerosis	Disease	MESH:C531617
16045483	234	238	fALS	Disease	MESH:C531617
16045483	473	499	neurodegenerative diseases	Disease	MESH:D019636
16045483	511	530	Alzheimer's disease	Disease	MESH:D000544
16045483	535	538	ALS	Disease	MESH:D008113
16045483	570	574	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	599	628	phosphatidylinositol-3-kinase	Gene	5295
16045483	637	640	Akt	Gene	207
16045483	674	683	caspase-3	Gene	836
16045483	693	699	VSC4.1	CellLine	CVCL:B0FV
16045483	739	743	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	768	773	hSOD1	Gene	6647
16045483	775	779	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	910	913	Akt	Gene	207
16045483	922	955	heat shock transcription factor-1	Gene	3297
16045483	957	963	HSTF-1	Gene	3297
16045483	966	978	cytochrome c	Gene	54205
16045483	980	989	caspase-3	Gene	836
16045483	994	1021	poly(ADP-ribose) polymerase	Gene	142
16045483	1023	1027	PARP	Gene	142
16045483	1124	1133	GSK-3beta	Gene	2932
16045483	1292	1301	GSK-3beta	Gene	2932
16045483	1376	1380	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	1385	1388	A4V	CellLine	CVCL:C4K6
16045483	1422	1426	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	1431	1434	A4V	CellLine	CVCL:C4K6
16045483	1446	1455	GSK-3beta	Gene	2932
16045483	1506	1512	HSTF-1	Gene	3297
16045483	1529	1541	cytochrome c	Gene	54205
16045483	1551	1560	caspase-3	Gene	836
16045483	1576	1580	PARP	Gene	142
16045483	1653	1656	Akt	Gene	207
16045483	1661	1670	GSK-3beta	Gene	2932
16045483	1703	1707	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	1739	1742	Akt	Gene	207
16045483	1756	1765	GSK-3beta	Gene	2932
16045483	1770	1779	caspase-3	Gene	836
16045483	1840	1849	GSK-3beta	Gene	2932
16045483	1896	1900	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:54205;RS#:11548779;CorrespondingSpecies:9606;CA#:154877770
16045483	Positive_Correlation	RS#:11548779;HGVS:c.93G>A;CorrespondingGene:54205	MESH:C531617
16045483	Positive_Correlation	142	2932
16045483	Negative_Correlation	2932	3297
16045483	Positive_Correlation	2932	836
16045483	Association	MESH:C531617	6647
16045483	Association	MESH:C531617	54205

